Clinical Laboratory Preparedness and Response Guide (Blue Book)

Total Page:16

File Type:pdf, Size:1020Kb

Clinical Laboratory Preparedness and Response Guide (Blue Book) TABLE OF CONTENTS Table of Contents ...................................................................................................................................................................................... 2 State Information ....................................................................................................................................................................................... 7 Introduction .............................................................................................................................................................................................. 10 Laboratory Response Network (LRN) .......................................................................................................................................... 15 Other Emergency Preparedness Response Information: .................................................................................................... 19 Radiological Threats ......................................................................................................................................................................... 21 Food Safety Threats .......................................................................................................................................................................... 25 BioWatch Program ............................................................................................................................................................................ 27 Bio Detection Systems – BDS......................................................................................................................................................... 28 Biosafety Basics ....................................................................................................................................................................................... 31 Biosafety Defined ............................................................................................................................................................................... 31 Biosafety Levels .................................................................................................................................................................................. 31 Laboratory Exposures and Lab Acquired Infections (LAIs) ................................................................................................. 34 Aerosol and Droplet Production .................................................................................................................................................. 35 BSL-3 Practices and When to Use BSL-3 Practices in a BSL-2 Laboratory ...................................................................... 37 Biological Risk Assessment.................................................................................................................................................................. 42 Risk Assessment: a 5-step Process Involving Hazard Identification and Hazard Control ........................................ 44 Biosecurity Basics .................................................................................................................................................................................... 46 Biosecurity Defined ........................................................................................................................................................................... 46 Biosecurity and Select Agents ....................................................................................................................................................... 46 Risk Management .............................................................................................................................................................................. 47 Example Guidance: A Biosecurity Risk Assessment and Management Process .......................................................... 47 Chain-of-Custody Guidance for Clinical Laboratories ............................................................................................................... 54 Regulations That Impact Clinical Laboratories ............................................................................................................................ 56 Select Agent Regulations ................................................................................................................................................................ 56 APHIS/CDC Forms .............................................................................................................................................................................. 56 What to do if you Suspect or Have a Confirmed Identification of a Select Agent ...................................................... 57 OSHA Bloodborne Pathogens Regulations .............................................................................................................................. 57 Clinical Laboratory improvement Act (CLIA) ........................................................................................................................... 61 Agents ......................................................................................................................................................................................................... 62 2 Quick Reference Guide to Specimen Collection of Suspected Agents of Bioterrorism & Emerging Infectious Diseases ................................................................................................................................................................................................. 63 Quick Reference Guide to Specimen Collection of Unknown Virus ................................................................................ 69 Quick Reference Guide to Specimen Collection for Botulism ........................................................................................... 71 Quick Reference Guide to Specimen Collection for Staphylococcal Enterotoxin B .................................................. 73 Bacillus anthracis (ANTHRAX) ........................................................................................................................................................ 75 Bacillus anthracis Identification Flowchart................................................................................................................................ 82 Brucella spp. (B. abortus, B. canis, B. melitensis, and B. suis) (BRUCELLOSIS) ................................................................... 85 Brucella Identification Flowchart ................................................................................................................................................ 102 Burkholderia mallei (GLANDERS) ................................................................................................................................................. 108 Burkholderia mallei Identification Flowchart.......................................................................................................................... 115 Burkholderia pseudomallei (MELIOIDOSIS) .............................................................................................................................. 118 Burkholderia pseudomallei Identification Flowchart............................................................................................................ 126 Francisella tularensis (TULAREMIA) ............................................................................................................................................ 129 Francisella tularensis Identification Flowchart ....................................................................................................................... 137 Yersinia pestis (PLAGUE) ................................................................................................................................................................. 140 Yersinia pestis Identification Flowchart .................................................................................................................................... 152 AlphaViruses ...................................................................................................................................................................................... 156 Botulinum Toxin (BoNT) Clostridium botulinum .................................................................................................................... 160 Coxiella burnetii (Q FEVER) ............................................................................................................................................................ 164 Orthopox viruses (SMALLPOX) ................................................................................................................................................... 169 Ricinus communis (RICININE) ........................................................................................................................................................ 173 Staphylococcal Enterotoxin B (SEB) Staphylococcus aureus ............................................................................................. 177 Viral Hemorrhagic Fevers (VHF) .................................................................................................................................................. 180 Packaging and Shipping ...................................................................................................................................................................
Recommended publications
  • Manual of Bacteriology
    m 4-1 /fo3 L CORNELL UNIVERSITY. THE THE GIFT OF ROSWELL P. FLOWER FOR THE USE OF THE N. Y. STATE VETERINARY COLLEGE ,,,. ^ 1897 8394-1 v3 Cornell University Library OR 41.M95 1903 Manual of bacteriology, 3 1924 000 225 965 Cornell University Library The original of tiiis book is in tine Cornell University Library. There are no known copyright restrictions in the United States on the use of the text. http://www.archive.org/details/cu31924000225965 MANUAL OF BACTERIOLOGY \ > rhe?yi><^- MANUAL OF BACTERIOLOGY BY ROBERT MUIR; M.A., M.D., F.R.C.P.Ed. PROFESSOR OF PATHOLOGY, UNIVERSITY OF GLASGOW, AND JAMES RITCHIE, M.A., M.D., B.Sc. T READER IN PATHOLOGY, UNIVERSITY OF OXFORD, AMERICAN EDITION (WITH ADDITIONS), REVISED AND EDITED FROM THE THIRD ENGLISH EDITION BY NORMAN MAC LEOD HARRIS, M.B. (Tor.) ASSOCIATE IN BACTERIOLOGY, THE JOHNS HOPKINS UNIVERSITY, BALTIMQRE. WITH ONE HUND/t^D &= i^ENlPC^LLUSTRATIONS. LIBRARY. THE MACMILLAN COMPANY. LONDON: MACMILLAN & CO., Ltd. 1903 T Jill rights reserved. -7 . "^ '%C; No. X5 G^ Copyright, 1903, By the macmillan company. Set up and electrotyped February, 1903. Norivood Press J. S. Cushing & Co. — Berwick & Smith Norwood, Mass., U.S.A. PREFACE TO THE AMERICAN EDITION. In presenting this the American edition of the well-known and appreciated work of Doctors Muir and Ritchie, the en- deavour has been made to add to the value of the book by giving adequate expression to the best in American laboratory methods and research, and, at the same time, to augment the general scope of the work -without eliminating the personal impress of the authors.
    [Show full text]
  • Poisoning by Medical Plants
    ARCHIVES OF ArchiveArch Iran Med.of SID February 2020;23(2):117-127 IRANIAN http www.aimjournal.ir MEDICINE Open Systematic Review Access Poisoning by Medical Plants Mohammad Hosein Farzaei, PhD1; Zahra Bayrami, PhD2; Fatemeh Farzaei, PhD1; Ina Aneva, PhD3; Swagat Kumar Das, PhD4; Jayanta Kumar Patra, PhD5; Gitishree Das, PhD5; Mohammad Abdollahi, PhD2* 1Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran 2Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), and School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran 3Institute of Biodiversity and Ecosystem Research, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria, Bulgaria 4Department of Biotechnology, College of Engineering and Technology, BPUT, Bhubaneswar 751003, Odisha, India 5Research Institute of Biotechnology & Medical Converged Science, Dongguk University-Seoul, Goyangsi 10326, Republic of Korea Abstract Background: Herbal medications are becoming increasingly popular with the impression that they cause fewer side effects in comparison with synthetic drugs; however, they may considerably contribute to acute or chronic poisoning incidents. Poison centers receive more than 100 000 patients exposed to toxic plants. Most of these cases are inconsiderable toxicities involving pediatric ingestions of medicinal plants in low quantity. In most cases of serious poisonings, patients are adults who have either mistakenly consumed a poisonous plant as edible or ingested the plant regarding to its medicinal properties for therapy or toxic properties for illegal aims. Methods: In this article, we review the main human toxic plants causing mortality or the ones which account for emergency medical visits. Articles addressing “plant poisoning” in online databases were listed in order to establish the already reported human toxic cases.
    [Show full text]
  • Clinical Laboratory Preparedness and Response Guide
    TABLE OF CONTENTS Table of Contents ...................................................................................................................................................................................... 2 State Information ....................................................................................................................................................................................... 7 Introduction .............................................................................................................................................................................................. 10 Laboratory Response Network (LRN) .......................................................................................................................................... 15 Other Emergency Preparedness Response Information: .................................................................................................... 19 Radiological Threats ......................................................................................................................................................................... 21 Food Safety Threats .......................................................................................................................................................................... 25 BioWatch Program ............................................................................................................................................................................ 27 Bio Detection Systems
    [Show full text]
  • Chapter 26 BIOSAFETY Appendix B. Pathogen and Toxin Lists B.1
    Chapter 26 BIOSAFETY ____________________ Appendix B. Pathogen and Toxin Lists B.1 Introduction and Scope Pathogens and toxins are discussed in detail in Work Process B.3.d, Pathogenic Agents and Toxins, of this manual. This appendix lists the following biological agents and toxins presented in Work Process B.3.d: Human etiologic agents (pathogens) from Appendix B of the NIH Guidelines Select agents and toxins from the National Select Agent Registry (NSAR) Plant pathogens previously identified by U.S. Department of Agriculture (USDA) These lists are provided for convenience in this manual, but may not reflect the actual regulatory list or applicable agents or materials. Regulatory sources, standards, and Web links noted in this appendix and Work Process B.3.d should be consulted to confirm applicable agents or toxins. B.2 NIH Guidelines Human Etiologic Agents This section provides a list of human pathogens and their Risk Group (RG) 2, RG3, and RG4 designations as excerpted from Appendix B, Classification of Human Etiologic Agents on the Basis of Hazard, of the NIH Guidelines, amendment effective November 6, 2013. B.2.1 Risk Group 1 Agents RG1 agents are not associated with disease in healthy adult humans. Examples of RG1 agents include asporogenic Bacillus subtilis or Bacillus licheniformis (see NIH Guidelines, Appendix C-IV-A, Bacillus subtilis or Bacillus licheniformis Host-Vector Systems, Exceptions); adeno-associated virus (AAV, all serotypes); and recombinant or synthetic AAV constructs, in which the transgene does not encode either a potentially tumorigenic gene product or a toxin molecule and which are produced in the absence of a helper virus.
    [Show full text]
  • Denotations & Old Terminologies Used in Homopathy
    Denotations & Old terminologies used in Homopathy Dr Jagathy Murali. Kerala Majority of the students and practitioners in Homeopathy experiencing great difficulty in understanding the meaning of old terminologies in various repertories and materia medicas. Hence this is an attempt to lessen the difficulties of practitioners and students. Acetonemia The presence of acetone bodies in relativly large amounts in blood,manifested at first by erethism,later by progressive depression Acne An inflammatory follucular,papular and pustular eruption involving the sebaceous apparatus Acne rosacea Rosasea;a chronic disease of the skin of the nose,forehead,and cheecks,marked by flushing,followed by red colouration due to dilatation of the capillaries,with the appearance of papules and acne like pustules. Acne simplex Acne vulgaris Acrid Sharp,pungent,biting,irritating Actinomycosis An infectious disease caused by actinomyces,marked by indolent inflammatory lesions of the lymph nodes draining the mouth,by inatraperitonial abcess,or by lung abcess due to aspiration. Adenitis Inflammation of a lymph node or of a gland Adenoid vegetations The adenoids, which spring from the vault of the pharynx, form masses varying in size from a small pea to an almond. They may be sessile, with broad bases, or pedunculated. They are reddish in color, of moderate firmness, and contain numerous blood-vessels. "abundant, as a rule, over the vault, on a line with the fossa of the eustachian tube, the growths may lie posterior to the fossa namely, in the depression known as the fossa of rosenmuller, or upon the parts which are parallel to the posterior wall of the pharynx.
    [Show full text]
  • ICAR-JRF Tutorial Question Bank. 2014. Veterinary College, KVAFSU
    KARNATAKA VETERINARY, ANIMAL AND FISHERIES SCIENCES UNIVERSITY, BIDAR-585 401 ICAR-JRF [Indian Council of Agricultural Research, New Delhi] TUTORIAL QUESTION BANK FOR THE BENEFIT OF: FINAL YEAR B.V.Sc & A.H STUDENTS VETERINARY COLLEGE, VINOBANAGAR SHIMOGA-577204 Tutorial Classes Conducted under SCP- TSP Grant from the Government of Karnataka [FY: 2013-14] Organized by: VETERINARY COLLEGE, SHIMOGA Karnataka Veterinary, Animal &Fisheries Sciences University Vinobanagar, Shimoga-577204 E.mail: [email protected] Tel: 08182-651001 KARNATAKA VETERINARY, ANIMAL AND FISHERIES SCIENCES UNIVERSITY, BIDAR-585 401 ICAR-JRF 1 [Indian Council of Agricultural Research, New Delhi] TUTORIAL QUESTION BANK FOR THE BENEFIT OF: FINAL YEAR B.V.Sc & A.H STUDENTS VETERINARY COLLEGE, VINOBANAGAR SHIMOGA-577204 Prepared by: Dr. PRAKSH NADOOR Professor& Head Department of Pharmacology & Toxicology Veterinary College, Shimoga-577204 Dr. LOKESH L.V Assistant Professor Department of Pharmacology & Toxicology Veterinary College, Shimoga-577204 and Dr.NAGARAJA . L Assistant Professor Department of Veterinary Medicine Veterinary College, Shimoga-577204 2 FORE WORD The Indian Council of Council Agricultural Research [ICAR],New Delhi is the apex body for co-ordinating, guiding and managing research and education in agriculture including horticulture, fisheries and animal sciences in the entire country. With 99 ICAR institutes and 53 agricultural universities (including veterinary universities) spread across the country this is one of the largest national agricultural systems in the world. Apart from above mandates of the Council, it is also encourgining student’s to undertake quality higher education in veterinary, agriculture, horticulture, forestry and fishery sciences, in a way to produce quality scientists required for not only for its premier research institutes spread across the country, but also to scale up with human resource development.
    [Show full text]
  • Investigation of How Endoplasmic Reticulum Stress Causes Insulin Resistance and Neuroinflammation
    Durham E-Theses INVESTIGATION OF HOW ENDOPLASMIC RETICULUM STRESS CAUSES INSULIN RESISTANCE AND NEUROINFLAMMATION BROWN, MAX,ADAM How to cite: BROWN, MAX,ADAM (2015) INVESTIGATION OF HOW ENDOPLASMIC RETICULUM STRESS CAUSES INSULIN RESISTANCE AND NEUROINFLAMMATION , Durham theses, Durham University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/11438/ Use policy The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that: • a full bibliographic reference is made to the original source • a link is made to the metadata record in Durham E-Theses • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders. Please consult the full Durham E-Theses policy for further details. Academic Support Oce, Durham University, University Oce, Old Elvet, Durham DH1 3HP e-mail: [email protected] Tel: +44 0191 334 6107 http://etheses.dur.ac.uk 2 INVESTIGATION OF HOW ENDOPLASMIC RETICULUM STRESS CAUSES INSULIN RESISTANCE AND NEUROINFLAMMATION Volume I Max Adam Brown This thesis is submitted as part of the requirements for the award of Degree of Doctor of Philosophy School of Biological and Biomedical Sciences Durham University July 2015 ABSTRACT Endoplasmic reticulum (ER) stress is caused by the accumulation of mis/unfolded proteins in the ER. ER stress signalling pathways termed the unfolded protein response are employed to alleviate ER stress through increasing the folding capacity and decreasing the folding demand of the ER as well as removing mis/unfolded proteins.
    [Show full text]
  • Survival After an Intentional Ingestion of Crushed Abrus Seeds
    UC Irvine Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health Title Survival after an Intentional Ingestion of Crushed Abrus Seeds Permalink https://escholarship.org/uc/item/6mk8r34r Journal Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health, 9(3) ISSN 1936-900X Authors Reedman, Lisa Shih, Richard D Hung, Oliver Publication Date 2008 Peer reviewed eScholarship.org Powered by the California Digital Library University of California CASE REP O RT Survival after an Intentional Ingestion of Crushed Abrus Seeds Lisa Reedman, MD* * Morristown Memorial Hospital Richard D. Shih, MD*† † New Jersey Medical School Oliver Hung, MD* Supervising Section Editor: Brandon K. Wills, DO, MS Submission history: Submitted December 23, 2007; Revision Received March 6, 2008; Accepted March 6, 2008. Reprints available through open access at www.westjem.org Abrus precatorius seeds contain one of the most potent toxins known to man. However, because of the seed’s outer hard coat the vast majority of ingestions cause only mild symptoms and typically results in complete recovery. If the seeds are crushed and then ingested, more serious toxicity, including death, can occur. We present a case of a man who survived an intentional ingestion of crushed Abrus seeds after he was treated with aggressive gastric decontamination and supportive care. [WestJEM. 2008;9:157-159.] INTRODUCTION Abrus precatorius is a vine native to India and other tropical and subtropical areas of the world. Since introduction to Florida and the Caribbean, it is now commonly found throughout these areas and in the southern United States.1 It is known by a variety of names, including jequirty bean, rosary pea, prayer bead, crab’s eye, and love bean.2 The vine has pods with oval seeds and a hard glossy shell.
    [Show full text]
  • Ueber Das Staphylotoxin
    [Aus dem kSnigl, preuss. Institut fiir experim. Therapie zu Frankfurt a/M.] (Director: Geh. Med.-Rath Prof. Dr. P. Ehrlich.) Ueber des Staphylotoxin. Ton Dr. ]Wax Neisser und Dr. Friedrieh Weehsberg. :~itglied des Instttuts. Yon bakteriologischer Seite wird fiber die Staphylokokken seit liingerer Zeit nicht mehr viel gearbeitet; ist doch auch die Zfichtung der Staphylo- kokken so leicht, dass schon in den ersten Zeiten der Bakterio]ogie die Staphylokokken Gegenstand der ausffihrlichsten Untersuchungen seitens Bakteriotogen, Klinikern und Pathologen gewesen stud. Und doch sind noch so manche Cardinalfragen unbeantwortet. So finden wit Staphylococci aurei im Eiter, auf der gesunden Haut, auf gesunden und kranken Schleimh~uten, in der Vaccine, in der Luft u. s. w,, and immer wieder erhebt sich die Frage: Ist des jedesmal der typische Staphylococcus pyogenes aureus, ja giebt es fiberhaupt eine circumscripte Species Staphylococcus pyogenes aureus, oder abet haben wit es, wie vielleicht bet den Streptokokken, mit verschiedenen, for den Menschen pathogenen A_rten zu thun? -- eine Frage, die in ihren therapeutischen un4 hygienisehen Consequenzeu gleich wichtig ist. Uud dieselbe Unsieher- heir besteht in vielleieht noch grSsserem ~Waasse fOr die weissen Staphy]o- kokken, hueh diese findet~ man sehr h~iuiig als augenscheinlich harmlose Saprophyten, bis man bet manchen Befunden wieder an ihre pathologische Bedeutung gemahnt wird. Auffallend wenig hat man sieh bisher nfit dem Gifte der Staphylo- kokken besch~ftigt. Wohl hat man gekochte oder ausgef~llte Bouillon- Vollculturen auf ihre Gfftigkeit untersucht (und ihre Wirkung nicht sehr betr~chtlich befunden), abet die Filtrate der Staphylokokken sind bisher 300 ~[AX ~]~ISSER UND ]~RIEDRICH ~[ECHSBERG: in systematischer Weise noch nicht yon sehr zahlreichen Forschern unter- sucht worden, so dass Frosch und Kolle in den Fliigge'schen Mikro- organismen im Jahre 1896 noch schreiben konnten: Von einer Secretion giftiger oder eitererregender Substanzen hat sich bei den Staphylokokken nichts nachweisen lassen.
    [Show full text]
  • Illustration Sources
    APPENDIX ONE ILLUSTRATION SOURCES REF. CODE ABR Abrams, L. 1923–1960. Illustrated flora of the Pacific states. Stanford University Press, Stanford, CA. ADD Addisonia. 1916–1964. New York Botanical Garden, New York. Reprinted with permission from Addisonia, vol. 18, plate 579, Copyright © 1933, The New York Botanical Garden. ANDAnderson, E. and Woodson, R.E. 1935. The species of Tradescantia indigenous to the United States. Arnold Arboretum of Harvard University, Cambridge, MA. Reprinted with permission of the Arnold Arboretum of Harvard University. ANN Hollingworth A. 2005. Original illustrations. Published herein by the Botanical Research Institute of Texas, Fort Worth. Artist: Anne Hollingworth. ANO Anonymous. 1821. Medical botany. E. Cox and Sons, London. ARM Annual Rep. Missouri Bot. Gard. 1889–1912. Missouri Botanical Garden, St. Louis. BA1 Bailey, L.H. 1914–1917. The standard cyclopedia of horticulture. The Macmillan Company, New York. BA2 Bailey, L.H. and Bailey, E.Z. 1976. Hortus third: A concise dictionary of plants cultivated in the United States and Canada. Revised and expanded by the staff of the Liberty Hyde Bailey Hortorium. Cornell University. Macmillan Publishing Company, New York. Reprinted with permission from William Crepet and the L.H. Bailey Hortorium. Cornell University. BA3 Bailey, L.H. 1900–1902. Cyclopedia of American horticulture. Macmillan Publishing Company, New York. BB2 Britton, N.L. and Brown, A. 1913. An illustrated flora of the northern United States, Canada and the British posses- sions. Charles Scribner’s Sons, New York. BEA Beal, E.O. and Thieret, J.W. 1986. Aquatic and wetland plants of Kentucky. Kentucky Nature Preserves Commission, Frankfort. Reprinted with permission of Kentucky State Nature Preserves Commission.
    [Show full text]
  • Botanical Medicine
    prohealth QUICK REFERENCE EVIDENCE INFORMED BOTANICAL MEDICINE ,ĞƌďƐ͕ŶƵƚƌŝƟŽŶ͕ŚŽƌŵŽŶĞƐΘŵĞĚŝĐĂƟŽŶƐ ƌ͘DĂƌŝƐĂDĂƌĐŝĂŶŽΘƌ͘EŝŬŝƚĂ͘sŝnjŶŝĂŬ Introduction ............... 1 Botanical Studying Tips ................. iii Plant Harvesting ............................ vi Intro Intro Food is Medicine ........7 3URWHLQIDW¿EHUFDUERK\GUDWHV .... 9 A Vitamins & minerals .......................14 B Actions ....................... 31 C Constituents............... 59 D Pharmacy ................... 73 E Monographs A-Z.... ..... 85 F Appendix .................... 370 G Toxicology, CIs & Safe Dosing .............370 +HUEVLQ3UHJQDQF\ ............................. 376 H +HUEVLQ3HGLDWULFV .............................. 377 I 13/(; ERDUGH[DPKHUEOLVW ............ 378 +HUEVE\)DPLO\ ................................... 379 J +HUE'UXJ1XWULHQW,QWHUDFWLRQV .......... 382 K Medications (drug & use) .....................386 L Index .......................... 403 +HUEVE\ODWLQQDPH ............................. 406 M +HUEVE\FRPPRQQDPH ..................... 407 N Congratulations RQPDNLQJWKHEHVWLQYHVWPHQWRI\RXUOLIH\RXURZQHGXFDWLRQDQG\RXU O FRQWLQXHGVHUYLFHWR\RXUSDWLHQW¶VTXDOLW\RIOLIH7RKHOSVXSSRUW\RXWKLVWH[WZDVFUHDWHG P DVWKHPRVWXSWRGDWHIXQFWLRQDODQGFRVWHIIHFWLYHFOLQLFDOWH[WDYDLODEOH&RXQWOHVVKRXUVRI UHVHDUFK GHVLJQZHUHVSHQWWRGHYHORSWKHFRQWHQW IRUPDW,QIRUPDWLRQVRXUFHVLQFOXGH Q KXQGUHGVRIRULJLQDOSHHUUHYLHZHGUHVHDUFKDUWLFOHVZLWKFXWWLQJHGJHLQIRUPDWLRQ GHFDGHVRI R HYLGHQFHLQIRUPHGEHVWSUDFWLFHV PXOWLGLVFLSOLQDU\FOLQLFDOH[SHULHQFHZLWKDIRFXVRQresults S based medicine. ,QRUGHUWRJHWWKHPRVWFOLQLFDOXWLOLW\IURPWKLVWH[WLWPXVWEHDYDLODEOHDWDOOWLPHVDVVXFK
    [Show full text]
  • July 2017 Toxtidbits
    July 2017 Poison Center Hotline: 1-800-222-1222 The Maryland Poison Center’s Monthly Update: News, Advances, Information Abrin The Maryland Poison Center was recently consulted on a case involving a suicidal adult who by history ingested 400‐500 “abrin” seeds that were bought on the in‐ ternet. The paent arrived at the emergency department approximately 5 hours later with hematemesis, abdominal pain and bloody diarrhea. Laboratory findings, including renal and liver funcon tests, were normal except for an elevated white blood cell count. Treatment included intravenous fluids, an‐emecs, and gastro‐ intesnal (GI) protectants. The paent remained symptomac with primarily (GI) effects for two weeks, and was medically cleared aer 16 days. Abrin is a natural plant toxin found in all parts of Abrus precartorius, a tropical plant also known as rosary pea, jequirity, jequirity bean, crab’s eye, John Crow Did you know? bead, precatory bean and Indian licorice. Abrin is a toxalbumin similar to ricin, a Abrus precartorius (rosary pea) toxin in Ricinus communis (aka castor bean). Abrin consists of A and B protein sub‐ seeds have been used as beads units. The B chain facilitates abrin’s transport into the cell, while the A chain pre‐ in necklaces and bracelets. vents protein synthesis inside the cell. Abrus precartorius seeds are red with a black spot and are less than one inch long. They have a hard outer shell which The bright, colorful seeds have been when ingested may pass though the GI tract without causing toxicity. However, used to make nave jewelry and crushing, chewing or puncturing the seeds releases the toxin, leading to toxicity.
    [Show full text]